{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:31:36Z","timestamp":1792657896907,"version":"4.5.0"},"reference-count":54,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["Senior Principal Research Fellowship APP1002486\/APP1103050"],"award-info":[{"award-number":["Senior Principal Research Fellowship APP1002486\/APP1103050"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The small molecule macrocyclic lactone ivermectin, approved by the US Food and Drug Administration for parasitic infections, has received renewed attention in the last eight years due to its apparent exciting potential as an antiviral. It was identified in a high-throughput chemical screen as inhibiting recognition of the nuclear localizing Human Immunodeficiency Virus-1 (HIV-1) integrase protein by the host heterodimeric importin (IMP) \u03b1\/\u03b21 complex, and has since been shown to bind directly to IMP\u03b1 to induce conformational changes that prevent its normal function in mediating nuclear import of key viral and host proteins. Excitingly, cell culture experiments show robust antiviral action towards HIV-1, dengue virus (DENV), Zika virus, West Nile virus, Venezuelan equine encephalitis virus, Chikungunya virus, Pseudorabies virus, adenovirus, and SARS-CoV-2 (COVID-19). Phase III human clinical trials have been completed for DENV, with &gt;50 trials currently in progress worldwide for SARS-CoV-2. This mini-review discusses the case for ivermectin as a host-directed broad-spectrum antiviral agent for a range of viruses, including SARS-CoV-2.<\/jats:p>","DOI":"10.3390\/cells9092100","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T10:24:09Z","timestamp":1600165449000},"page":"2100","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5115-4745","authenticated-orcid":false,"given":"David A.","family":"Jans","sequence":"first","affiliation":[{"name":"Nuclear Signaling Lab., Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Monash, Victoria 3800, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie M.","family":"Wagstaff","sequence":"additional","affiliation":[{"name":"Cancer Targeting and Nuclear Therapeutics Lab., Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Monash, Victoria 3800, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2183\/pjab.87.13","article-title":"Ivermectin, wonder drug from Japan: The human use perspective","volume":"87","author":"Crump","year":"2011","journal-title":"Proc. Jpn. Acad."},{"key":"ref_2","unstructured":"Nobel Foundation (2020, September 11). The Nobel Prize in Medicine or Physiology. Available online: https:\/\/www.nobelprize.org\/prizes\/medicine\/2015\/press-release."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1208\/s12248-007-9000-9","article-title":"The pharmacokinetics and interactions of ivermectin in humans\u2014A mini-review","volume":"10","year":"2008","journal-title":"AAPSJ"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pt.2014.07.005","article-title":"Ivermectin: Panacea for resource-poor communities?","volume":"30","author":"Crump","year":"2014","journal-title":"Trends Parasitol."},{"key":"ref_5","unstructured":"World Health Organization (2020, September 11). World Health Organization\u2019s List of Essential Medicines 21st List 2019. Available online: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/325771\/WHO-MVP-EMP-IAU-2019.06-eng.pdf."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.9734\/jammr\/2020\/v32i1030512","article-title":"A Wonder Drug in the Arsenal against COVID\u201419: Medication Evidence from Ivermectin","volume":"32","author":"Kumar","year":"2020","journal-title":"J. Adv. Med. Med. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1042\/BJ20120150","article-title":"Ivermectin is a specific inhibitor of importin \u03b1\/\u03b2-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus","volume":"443","author":"Wagstaff","year":"2012","journal-title":"Biochem. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.antiviral.2013.06.002","article-title":"Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin","volume":"99","author":"Tay","year":"2013","journal-title":"Antivir. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.antiviral.2013.10.004","article-title":"Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication","volume":"100","author":"Lundberg","year":"2013","journal-title":"Antivir. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"23138","DOI":"10.1038\/srep23138","article-title":"Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import","volume":"6","author":"Gotz","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"104760","DOI":"10.1016\/j.antiviral.2020.104760","article-title":"The broad spectrum antiviral ivermectin targets the host nuclear transport importin \u03b1\/\u03b21 heterodimer","volume":"177","author":"Yang","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Lvermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: New prospects for an old drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41598-017-18742-8","article-title":"Recognition by host nuclear transport proteins drives disorder-to-order transition in Hendra virus V","volume":"8","author":"Atkinson","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ceb.2019.01.001","article-title":"Inhibitors of nuclear transport","volume":"58","author":"Jans","year":"2019","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.antiviral.2015.12.012","article-title":"Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses","volume":"126","author":"Varghese","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.antiviral.2018.01.007","article-title":"Identification of novel antivirals inhibiting recognition of Venezuelan equine encephalitis virus capsid protein by the Importin \u03b1\/\u03b21 heterodimer through high-throughput screening","volume":"151","author":"Thomas","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.antiviral.2018.09.010","article-title":"Ivermectin inhibits DNA polymerase UL42 of Pseudorabies virus entrance into the nucleus and proliferation of the virus in vitro and vivo","volume":"159","author":"Lv","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virol.2014.10.013","article-title":"Role of a nuclear localization signal on the minor capsid proteins VP2 and VP3 in BKPyV nuclear entry","volume":"474","author":"Bennett","year":"2015","journal-title":"Virology"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"King, C.R., Tessier, T.M., Dodge, M.J., Weinberg, J.B., and Mymryk, J.S. (2020). Lnhibition of human adenovirus replication by the importin \u03b1\/\u03b21 nuclear import inhibitor ivermectin. J. Virol., in press.","DOI":"10.1128\/JVI.00710-20"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5802\/crbiol.8","article-title":"A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications","volume":"343","author":"Changeux","year":"2020","journal-title":"Comptes Rendus Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1124\/mol.53.2.283","article-title":"Lvermectin: A positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor","volume":"53","author":"Krause","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/009127002237994","article-title":"Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects","volume":"42","author":"Guzzo","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"ref_24","unstructured":"Brunton, L.L., Lazo, J.S., and Parker, K.L. (2006). Chemotherapy of helminth infections. Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics, McGraw Hill. [11th ed.]."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/jac\/dkz524","article-title":"Safety of high-dose ivermectin: A systematic review and meta-analysis","volume":"75","author":"Navarro","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1046\/j.1365-3156.2003.01091.x","article-title":"Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis","volume":"8","author":"Meredith","year":"2003","journal-title":"Trop. Med. Int. Health"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.bbamcr.2011.03.019","article-title":"Regulation of nucleocytoplasmic trafficking of viral proteins; an integral role in pathogenesis ?","volume":"1813","author":"Fulcher","year":"2011","journal-title":"Biochem. Biophys. Acta Mol. Cell Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.antiviral.2012.06.008","article-title":"Nuclear trafficking of proteins from RNA viruses: Potential target for anti-virals?","volume":"95","author":"Caly","year":"2012","journal-title":"Antivir. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Yang, S.N.Y., Atkinson, S.C., Fraser, J.E., Wang, C., Maher, B., Roman, N., Forwood, J.K., Wagstaff, K.M., Borg, N.A., and Jans, D.A. (2019). Novel Flavivirus Antiviral That Targets The Host Nuclear Transport Importin \u03b1\/\u03b21 Heterodimer. Cells, 8.","DOI":"10.3390\/cells8030281"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1600-0854.2007.00579.x","article-title":"Nuclear localization of dengue virus nonstructural protein 5 through its importin alpha\/beta-recognized nuclear localization sequences is integral to viral infection","volume":"8","author":"Pryor","year":"2007","journal-title":"Traffic"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/infdis\/jiu319","article-title":"A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection","volume":"210","author":"Fraser","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"9812","DOI":"10.1128\/JVI.01012-07","article-title":"Severe Acute Respiratory Syndrome Coronavirus ORF6 Antagonizes STAT1 Function by Sequestering Nuclear Import Factors on the Rough Endoplasmic Reticulum\/Golgi Membrane","volume":"81","author":"Frieman","year":"2007","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"17554","DOI":"10.1038\/srep17554","article-title":"Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets","volume":"5","author":"Yang","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1087057110390360","article-title":"An AlphaScreen(R)-based assay for high-throughput screening for specific inhibitors of nuclear import","volume":"16","author":"Wagstaff","year":"2011","journal-title":"J. Biomol. Screen."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Wagstaff, K.M., Headey, S., Telwatte, S., Tyssen, D., Hearps, A.C., Thomas, D.R., Tachedjian, G., and Jans, D.A. (2018). Molecular dissection of an inhibitor targeting the HIV integrase dependent preintegration complex nuclear import. Cell. Microbiol., e12953.","DOI":"10.1111\/cmi.12953"},{"key":"ref_36","first-page":"e12848","article-title":"Nucleocytoplasmic shuttling of the West Nile virus RNA-dependent RNA polymerase NS5 is critical to infection","volume":"20","author":"Russo","year":"2018","journal-title":"Cell. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1472-8206.2009.00684.x","article-title":"Avermectin exerts anti-inflammatory effect by downregulating the nuclear transcription factor kappa-B and mitogen-activated protein kinase activation pathway","volume":"23","author":"Ci","year":"2009","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2605.1998.00091.x","article-title":"Gossypol as a male antifertility agent\u2014Why studies should have been continued","volume":"21","author":"Yu","year":"1998","journal-title":"Int. J. Androl."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/mrd.1080250414","article-title":"Effects of Gossypol on the Motility of Mammalian Sperm","volume":"21","author":"Porat","year":"1990","journal-title":"Mol. Reprod. Dev."},{"key":"ref_40","unstructured":"Yamasmith, E., Saleh-arong, F.A., Avirutnan, P., Angkasekwinai, N., Mairiang, D., Wongsawat, E., Tanrumluk, S., Fongsri, U., and Suputtamongkol, Y. (2018, January 26\u201328). Efficacy and Safety of Ivermectin against Dengue Infection: A Phase III, Randomized, Double-blind, Placebo-controlled Trial. Proceedings of the 34th Annual Meeting The Royal College of Physicians of Thailand\u2014\u2018Internal Medicine and One Health\u2019, Pattaya, Thailand."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Brady, O.J., Gething, P.W., Bhatt, S., Messina, J.P., Brownstein, J.S., Hoen, A.G., Moyes, C.L., Farlow, A.W., Scott, T.W., and Hay, S.I. (2012). Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus. PLoS Negl. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001760"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa2016638","article-title":"A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19","volume":"383","author":"Boulware","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_44","unstructured":"US Food and Drug Administration (2020, September 11). Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine, Available online: https:\/\/www.fda.gov\/media\/138945."},{"key":"ref_45","unstructured":"US Food and Drug Administration (2020, September 11). FDA Cautions against Use of Hydroxychloroquine or Chloroquine for COVID-19 Outside of the Hospital Setting or a Clinical Trial due to Risk of Heart Rhythm Problems, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2020\/OSE%20Review_Hydroxychloroquine-Cholorquine%20-%2019May2020_Redacted.pdf."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A Trial of Lopinavir\u2013Ritonavir in Adults Hospitalized with Severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: A randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Arshad, U., Pertinez, H., Box, H., Tatham, L., Rajoli, R.K.R., Curley, P., Neary, M., Sharp, J., Liptrott, N.J., and Valentijn, A. (2020). Prioritisation of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived From Their Established Human Pharmacokinetics. Clin. Pharm. Ther.","DOI":"10.1101\/2020.04.16.20068379"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Schmith, V.D., Zhou, J.J., and Lohmer, L.R. (2020). The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19. Clin. Pharm. Ther.","DOI":"10.1101\/2020.04.21.20073262"},{"key":"ref_50","unstructured":"Trial Site News (2020, September 11). Eurnekian Public Hospital Argentina\u2019s IVERCAR Ivermectin & Carrageenan Study Shows Positive Results Targeting COVID-19. Available online: https:\/\/www.trialsitenews.com\/argentinas-ivercar-ivermectin-carrageenan-study-shows-positive-results-targeting-covid-19\/."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3329\/jbcps.v38i0.47512","article-title":"A Case Series of 100 COVID-19 Positive Patients Treated with Combination of Ivermectin and Doxycycline","volume":"38","author":"Alam","year":"2020","journal-title":"Bangladesh Coll. Phys. Surg."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3329\/jbcps.v38i0.47514","article-title":"Comparison of Viral Clearance between Ivermectin with Doxycycline and Hydroxychloroquine with Azithromycin in COVID-19 Patients","volume":"38","author":"Rahman","year":"2020","journal-title":"Bangladesh Coll. Phys. Surg."},{"key":"ref_53","unstructured":"Republica Del Peru Ministerio De Salud (2020, September 11). RM_270-2020-MINSA. Available online: https:\/\/cdn.www.gob.pe\/uploads\/document\/file\/694719\/RM_270-2020-MINSA.PDF."},{"key":"ref_54","unstructured":"The Gobierno del Estate Plurinacional de Bolivia Misterio de Salud (2020, September 11). Ministerial Resolution No 259 from the Gobierno del Estate Plurinacional de Bolivia Misterio de Salud. Available online: https:\/\/www.minsalud.gob.bo\/component\/jdownloads\/send\/27-comunicado-oficial\/425-resolucion-ministerial-n-0259."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/9\/2100\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:10:12Z","timestamp":1760177412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/9\/2100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":54,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["cells9092100"],"URL":"https:\/\/doi.org\/10.3390\/cells9092100","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]}}}